Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Uterine Fibroids Treatment Global Market Report 2025
Download Free Sample Buy Now
Global Uterine Fibroids Treatment Market Report 2025

Report Price : $4490.00

Pages :

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Uterine Fibroids Treatment Global Market Report 2025

By Type (Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids, Pedunculated Fibroids), By Treatment Type (Hormone Therapy, Androgens, Gonadotropin-Releasing Hormone Antagonists, Uterine Artery Embolization, Myomectomy, Hysterectomy), By End-Users (Hospitals, Ambulatory Surgical Centers, Other End users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Uterine Fibroids Treatment Market Overview

• Uterine Fibroids Treatment market size has reached to $4.06 billion in 2024

• Expected to grow to $6.43 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%

• Growth Driver: Rising Prevalence Of Uterine Fibroids Propels Growth In Treatment Market

• Market Trend: Innovative Uterine Fibroid Treatment Kissei Launches Non-Hormonal Therapy YSELTY

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Uterine Fibroids Treatment Market?

Uterine fibroids treatment refers to treatment procedures related to uterine fibroids. Uterine fibroids are non-cancerous growths that develop in the uterus and can cause symptoms such as heavy menstrual bleeding, pelvic pain, and pressure on the bladder or bowel.

The main types of uterine fibroids treatment include subserosal fibroids, intramural fibroids, submucosal fibroids, and pedunculated fibroids. Subserosal fibroids refer to a benign development on the outer uterine wall also called a pedunculated fibroid which is directly connected to the uterus. It consists of various treatment types such as hormone therapy, androgens, Gonadotropin-Releasing Hormone Antagonists, uterine artery embolization, myomectomy, and hysterectomy for use in end-users such as hospitals, ambulatory surgical centers, and others.

Uterine Fibroids Treatment Market Size and growth rate 2025 to 2029: Graph

What Is The Uterine Fibroids Treatment Market Size 2025 And Growth Rate?

The uterine fibroids treatment market size has grown strongly in recent years. It will grow from$4.06 billion in 2024 to $4.43 billion in 2025 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to increased incidence of uterine fibroids, advancements in diagnostic techniques, rising awareness and education, impact on quality of life, evolution of minimally invasive procedures

What Is The Uterine Fibroids Treatment Market Growth Forecast?

The uterine fibroids treatment market size is expected to see strong growth in the next few years. It will grow to $6.43 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to advancements in non-invasive treatment, increasing emphasis on fertility preservation, rise in minimally invasive techniques, personalized medicine approaches, collaborative research and development. Major trends in the forecast period include rising focus on fertility-preserving treatments, integration of imaging technologies in treatment planning, increasing awareness and education initiatives, customized treatment plans based on patient profiles, exploration of novel therapeutic targets.

The forecast of 9.8% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. patients by driving up the cost of Magnetic resonance imaging -guided focused ultrasound systems and progesterone modulators sourced from Israel and Canada, exacerbating surgical delays and increasing gynecology department costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Uterine Fibroids Treatment Market Segmented?

1) By Type: Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids, Pedunculated Fibroids

2) By Treatment Type: Hormone Therapy, Androgens, Gonadotropin-Releasing Hormone Antagonists, Uterine Artery Embolization, Myomectomy, Hysterectomy

3) By End-Users: Hospitals, Ambulatory Surgical Centers, Other End users

Subsegments:

1) By Subserosal Fibroids: Pedunculated Subserosal Fibroids, Non-Pedunculated Subserosal Fibroids

2) By Intramural Fibroids: Small Intramural Fibroids, Large Intramural Fibroids

3) By Submucosal Fibroids: Pedunculated Submucosal Fibroids, Non-Pedunculated Submucosal Fibroids

4) By Pedunculated Fibroids: Subserosal Pedunculated Fibroids, Submucosal Pedunculated Fibroids

What Is Driving The Uterine Fibroids Treatment Market? Rising Prevalence Of Uterine Fibroids Propels Growth In Treatment Market

The high prevalence of uterine fibroids among women is expected to propel the growth of the uterine fibroids treatment market going forward. Uterine fibroids refer to non-cancerous growths that develop in the uterus and can cause symptoms such as heavy menstrual bleeding, pelvic pain, and pressure on the bladder or bowel. Uterine fibroids treatment treats fibroids by blocking the production of estrogen and progesterone and stopping menstruation and improving anemia. For instance, in November 2022, according to a report published by the National Centre for Biotechnology Information, a US-based organization, and branch of the National Institutes of Health, the approximate incidence of uterine fibroids occurs between 40 and 60% among women under the age of 35 and between 70- 80% among women over the age of 50. Therefore, the high prevalence of uterine fibroids among women worldwide is driving the growth of the uterine fibroids treatment industry.

What Is Driving The Uterine Fibroids Treatment Market? Surge In Healthcare Expenditure Boosts Uterine Fibroids Treatment Market Growth

Increase in healthcare expenditure is expected to propel the growth of the uterine fibroids treatment market going forward. Healthcare expenditure refers to the total amount of resources, typically financial, that a country, government, organization, or individual spends on healthcare-related goods and services within a specific period. Higher healthcare expenditure can contribute to the development and adoption of advanced treatment options for uterine fibroids. This may include minimally invasive procedures, such as uterine artery embolization or magnetic resonance-guided focused ultrasound surgery. For instance, according to Statistics Poland, a Poland-based Government Agency, expenditure on healthcare in 2022 amounted to PLN 205.6 billion ($50.99) billion (representing 6.7% of GDP (gross domestic product)) and was higher than in 2021 by about PLN 36.1 billion ($8.95) billion. Therefore, the growing healthcare expenditure is driving the growth of the uterine fibroids treatment industry.

Who Are The Major Players In The Global Uterine Fibroids Treatment Market?

Major companies operating in the uterine fibroids treatment market include Gynesonics Inc., Medtronic plc, Boston Scientific Corporation, Karl Storz GmbH, Pfizer Inc., Abbvie Inc., Richard Wolf GmbH, CooperSurgical Inc., Olympus Corporation, Myovant Sciences GmbH, Insightec Ltd., Hologic Inc., Obseva SA, Eli Lilly and Company, GlaxoSmithKline plc, Stryker Corporation, Smith & Nephew plc, Minerva Surgical Inc., Ethicon Inc., Cook Medical LLC, C.R. Bard Inc., Biomerics LLC, Visionsense Corp., Halt Medical Inc., Acessa Health Inc., Blue Endo, LiNA Medical ApS, Merit Medical Systems Inc., Allergan plc, Astellas Pharma Inc.

What Are The Key Trends Of The Global Uterine Fibroids Treatment Market? Innovative Uterine Fibroid Treatment Kissei Launches Non-Hormonal Therapy YSELTY

Product innovations are a key trend gaining popularity in the uterine fibroid treatment market. Companies operating in the uterine fibroid treatment market are adopting innovative products to sustain their position in the market. For instance, in September 2024, Kissei Pharmaceutical Co., Ltd., a Japan-based pharmaceutical company, launched YSELTY, a treatment for uterine fibroids, marking a significant advancement in women's healthcare. YSELTY offers a non-hormonal treatment option, providing flexible dosing tailored to individual patient needs, particularly for those with severe fibroid symptoms. As a GnRH receptor antagonist, YSELTY reduces estrogen production by inhibiting gonadotropin-releasing hormone at its pituitary receptors, effectively alleviating symptoms such as bleeding and pain.

What Are The Key Trends Of The Global Uterine Fibroids Treatment Market? Innovation With Minimally Invasive Approaches In Uterine Fibroids Treatment

Major companies operating in the uterine fibroids treatment market are focusing on developing minimally invasive procedures for treating uterine fibroids. Minimally invasive procedures (MIPs) refer to medical interventions or surgeries that are performed with the least possible disruption to the body's normal structure and function. These procedures are designed to alleviate symptoms, such as heavy menstrual bleeding and pelvic pain, while minimizing recovery times and preserving reproductive options. For instance, in November 2022, Humber River Hospital a Canada-based acute care hospital has launched the use of the Acessa ProVu system, a new way to treat uterine fibroids. The Acessa ProVu system is a medical technology designed to deliver monopolar radiofrequency (RF) energy to tissue through a disposable Handpiece. It is indicated for use in percutaneous, laparoscopic coagulation, and ablation of soft tissue, including the treatment of symptomatic uterine fibroids.

Need data on a specific region in this market?
Request Regional Data

Uterine Fibroids Treatment Market Merger And Acquisition: Hologic Strengthens Gynecological Surgical Presence With $80 Million Acquisition Of Acessa Health

In January 2022, Hologic Inc., a US-based medical technology company acquired Acessa Health for $80 million. With this acquisition, Hologic’s presence in the gynecological surgical space is expected to strengthen with its access to Acessa Health’s Acessa ProVu system. Acessa Health is a US-based biotechnology company that develops minimally invasive, uterine-sparing devices intended to treat women who suffer from symptomatic fibroid.

Regional Analysis For The Global Uterine Fibroids Treatment Market

North America was the largest region in the uterine fibroids treatment market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Uterine Fibroids Treatment Market?

The uterine fibroids treatment market includes revenues earned by entities by providing medical, surgical, and radiologically guided therapies available as treatments for uterine fibroids. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Uterine Fibroids Treatment Industry?

The uterine fibroids treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the uterine fibroids treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Uterine Fibroids Treatment Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $4.43 billion
Revenue Forecast In 2034 $6.43 billion
Growth Rate CAGR of 9.8% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Type: Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids, Pedunculated Fibroids
2) By Treatment Type: Hormone Therapy, Androgens, Gonadotropin-Releasing Hormone Antagonists, Uterine Artery Embolization, Myomectomy, Hysterectomy
3) By End-Users: Hospitals, Ambulatory Surgical Centers, Other End users Subsegments: 1) By Subserosal Fibroids: Pedunculated Subserosal Fibroids, Non-Pedunculated Subserosal Fibroids
2) By Intramural Fibroids: Small Intramural Fibroids, Large Intramural Fibroids
3) By Submucosal Fibroids: Pedunculated Submucosal Fibroids, Non-Pedunculated Submucosal Fibroids
4) By Pedunculated Fibroids: Subserosal Pedunculated Fibroids, Submucosal Pedunculated Fibroids
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Gynesonics Inc., Medtronic plc, Boston Scientific Corporation, Karl Storz GmbH, Pfizer Inc., Abbvie Inc., Richard Wolf GmbH, CooperSurgical Inc., Olympus Corporation, Myovant Sciences GmbH, Insightec Ltd., Hologic Inc., Obseva SA, Eli Lilly and Company, GlaxoSmithKline plc, Stryker Corporation, Smith & Nephew plc, Minerva Surgical Inc., Ethicon Inc., Cook Medical LLC, C.R. Bard Inc., Biomerics LLC, Visionsense Corp., Halt Medical Inc., Acessa Health Inc., Blue Endo, LiNA Medical ApS, Merit Medical Systems Inc., Allergan plc, Astellas Pharma Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Uterine Fibroids Treatment Market Characteristics

3. Uterine Fibroids Treatment Market Trends And Strategies

4. Uterine Fibroids Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Uterine Fibroids Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Uterine Fibroids Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Uterine Fibroids Treatment Market Growth Rate Analysis

5.4. Global Uterine Fibroids Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Uterine Fibroids Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Uterine Fibroids Treatment Total Addressable Market (TAM)

6. Uterine Fibroids Treatment Market Segmentation

6.1. Global Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Subserosal Fibroids

Intramural Fibroids

Submucosal Fibroids

Pedunculated Fibroids

6.2. Global Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hormone Therapy

Androgens

Gonadotropin-Releasing Hormone Antagonists

Uterine Artery Embolization

Myomectomy

Hysterectomy

6.3. Global Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Ambulatory Surgical Centers

Other End users

6.4. Global Uterine Fibroids Treatment Market, Sub-Segmentation Of Subserosal Fibroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pedunculated Subserosal Fibroids

Non-Pedunculated Subserosal Fibroids

6.5. Global Uterine Fibroids Treatment Market, Sub-Segmentation Of Intramural Fibroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Small Intramural Fibroids

Large Intramural Fibroids

6.6. Global Uterine Fibroids Treatment Market, Sub-Segmentation Of Submucosal Fibroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pedunculated Submucosal Fibroids

Non-Pedunculated Submucosal Fibroids

6.7. Global Uterine Fibroids Treatment Market, Sub-Segmentation Of Pedunculated Fibroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Subserosal Pedunculated Fibroids

Submucosal Pedunculated Fibroids

7. Uterine Fibroids Treatment Market Regional And Country Analysis

7.1. Global Uterine Fibroids Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Uterine Fibroids Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Uterine Fibroids Treatment Market

8.1. Asia-Pacific Uterine Fibroids Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Uterine Fibroids Treatment Market

9.1. China Uterine Fibroids Treatment Market Overview

9.2. China Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Uterine Fibroids Treatment Market

10.1. India Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Uterine Fibroids Treatment Market

11.1. Japan Uterine Fibroids Treatment Market Overview

11.2. Japan Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Uterine Fibroids Treatment Market

12.1. Australia Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Uterine Fibroids Treatment Market

13.1. Indonesia Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Uterine Fibroids Treatment Market

14.1. South Korea Uterine Fibroids Treatment Market Overview

14.2. South Korea Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Uterine Fibroids Treatment Market

15.1. Western Europe Uterine Fibroids Treatment Market Overview

15.2. Western Europe Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Uterine Fibroids Treatment Market

16.1. UK Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Uterine Fibroids Treatment Market

17.1. Germany Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Uterine Fibroids Treatment Market

18.1. France Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Uterine Fibroids Treatment Market

19.1. Italy Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Uterine Fibroids Treatment Market

20.1. Spain Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Uterine Fibroids Treatment Market

21.1. Eastern Europe Uterine Fibroids Treatment Market Overview

21.2. Eastern Europe Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Uterine Fibroids Treatment Market

22.1. Russia Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Uterine Fibroids Treatment Market

23.1. North America Uterine Fibroids Treatment Market Overview

23.2. North America Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Uterine Fibroids Treatment Market

24.1. USA Uterine Fibroids Treatment Market Overview

24.2. USA Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Uterine Fibroids Treatment Market

25.1. Canada Uterine Fibroids Treatment Market Overview

25.2. Canada Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Uterine Fibroids Treatment Market

26.1. South America Uterine Fibroids Treatment Market Overview

26.2. South America Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Uterine Fibroids Treatment Market

27.1. Brazil Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Uterine Fibroids Treatment Market

28.1. Middle East Uterine Fibroids Treatment Market Overview

28.2. Middle East Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Uterine Fibroids Treatment Market

29.1. Africa Uterine Fibroids Treatment Market Overview

29.2. Africa Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Uterine Fibroids Treatment Market Competitive Landscape And Company Profiles

30.1. Uterine Fibroids Treatment Market Competitive Landscape

30.2. Uterine Fibroids Treatment Market Company Profiles

30.2.1. Gynesonics Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Karl Storz GmbH Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Uterine Fibroids Treatment Market Other Major And Innovative Companies

31.1. Abbvie Inc.

31.2. Richard Wolf GmbH

31.3. CooperSurgical Inc.

31.4. Olympus Corporation

31.5. Myovant Sciences GmbH

31.6. Insightec Ltd.

31.7. Hologic Inc.

31.8. Obseva SA

31.9. Eli Lilly and Company

31.10. GlaxoSmithKline plc

31.11. Stryker Corporation

31.12. Smith & Nephew plc

31.13. Minerva Surgical Inc.

31.14. Ethicon Inc.

31.15. Cook Medical LLC

32. Global Uterine Fibroids Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Uterine Fibroids Treatment Market

34. Recent Developments In The Uterine Fibroids Treatment Market

35. Uterine Fibroids Treatment Market High Potential Countries, Segments and Strategies

35.1 Uterine Fibroids Treatment Market In 2029 - Countries Offering Most New Opportunities

35.2 Uterine Fibroids Treatment Market In 2029 - Segments Offering Most New Opportunities

35.3 Uterine Fibroids Treatment Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Uterine Fibroids Treatment Market, Sub-Segmentation Of Subserosal Fibroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Uterine Fibroids Treatment Market, Sub-Segmentation Of Intramural Fibroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Uterine Fibroids Treatment Market, Sub-Segmentation Of Submucosal Fibroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Uterine Fibroids Treatment Market, Sub-Segmentation Of Pedunculated Fibroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Uterine Fibroids Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Uterine Fibroids Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Gynesonics Inc. Financial Performance
  • Table 79: Medtronic plc Financial Performance
  • Table 80: Boston Scientific Corporation Financial Performance
  • Table 81: Karl Storz GmbH Financial Performance
  • Table 82: Pfizer Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Uterine Fibroids Treatment Market, Sub-Segmentation Of Subserosal Fibroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Uterine Fibroids Treatment Market, Sub-Segmentation Of Intramural Fibroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Uterine Fibroids Treatment Market, Sub-Segmentation Of Submucosal Fibroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Uterine Fibroids Treatment Market, Sub-Segmentation Of Pedunculated Fibroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Uterine Fibroids Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Uterine Fibroids Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Uterine Fibroids Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Uterine Fibroids Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Uterine Fibroids Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Gynesonics Inc. Financial Performance
  • Figure 79: Medtronic plc Financial Performance
  • Figure 80: Boston Scientific Corporation Financial Performance
  • Figure 81: Karl Storz GmbH Financial Performance
  • Figure 82: Pfizer Inc. Financial Performance

Intestinal Fistula Treatment Market Overview 2025: Competitive Shifts, Forecast Models, and Emerging Opportunities

Read More About Intestinal Fistula Treatment Market Overview 2025: Competitive Shifts, Forecast Models, and Emerging Opportunities

Next-Gen Invasive Aspergillosis Therapeutics : Market Forecast, Transformation, and Long-Term Trajectories

Read More About Next-Gen Invasive Aspergillosis Therapeutics : Market Forecast, Transformation, and Long-Term Trajectories

Iron Deficiency Anemia Growth Trajectory: Key Forecasts and Strategic Insights

Read More About Iron Deficiency Anemia Growth Trajectory: Key Forecasts and Strategic Insights

Lewy Body Dementia Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Read More About Lewy Body Dementia Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Read More About A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Uterine Fibroids Treatment Global Market Report 2025 – By Type (Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids, Pedunculated Fibroids), By Treatment Type (Hormone Therapy, Androgens, Gonadotropin-Releasing...

View Report

Uterine Fibroids Treatment Global Market Report 2025 – By Type (Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids, Pedunculated Fibroids), By Treatment Type (Hormone Therapy, Androgens, Gonadotropin-Releasing...

View Report

Uterine Fibroid Embolization Device Global Market Report 2025 – By Technology (Surgical Techniques, Laparoscopic Techniques, Ablation Techniques, Embolization Techniques), By Mode Of Treatment (Invasive Treatment, Minima...

View Report

Endometrial Cancer Treatment Global Market Report 2025 – By Type (Adenocarcinoma, Uterine Carcinosarcoma, Squamous Cell Carcinoma, Small Cell Carcinoma, Transitional Carcinoma, Serous Carcinoma, Other Types), By Diagnosi...

View Report

Endometrial Ablation Devices Global Market Report 2025 – By Device Type (Hysteroscopy Devices, Thermal Balloon Ablators, Radiofrequency Endometrial Ablation Devices, Hydrothermal Ablators, Electrical Ablators, Other Devi...

View Report

Gynecology Drugs Global Market Report 2025 – By Therapeutics (Hormonal Therapy, Non-Hormonal Therapy), By Indication (Gynecology Cancers, Menopausal Disorder, Polycystic Ovary Syndrome, Contraception, Other Indications),...

View Report

Fibromyalgia Treatment Global Market Report 2025 – By Type (Symptomatic Treatment, Targeted Treatment), By Drug Class (Antidepressants, Antiepileptics, Muscle Relaxants, Analgesics, Other Drugs), By Distribution Channel ...

View Report

Neurofibromatosis Treatment Global Market Report 2025 – By Type (Neurofibromatosis 1 (NF–, Neurofibromatosis 2 (NF, Schwannomatosis), By Treatment (Medications, Surgery, Radiation Therapy, Other Treatments), By End-Users...

View Report

Frequently Asked Questions

Uterine fibroids treatment refers to treatment procedures related to uterine fibroids. Uterine fibroids are non-cancerous growths that develop in the uterus and can cause symptoms such as heavy menstrual bleeding, pelvic pain, and pressure on the bladder or bowel. For further insights on this market, request a sample here

The market major growth driver - Rising Prevalence Of Uterine Fibroids Propels Growth In Treatment Market. For further insights on this market, request a sample here

The uterine fibroids treatment market size has grown strongly in recent years. It will grow from $4.06 billion in 2024 to $4.43 billion in 2025 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to increased incidence of uterine fibroids, advancements in diagnostic techniques, rising awareness and education, impact on quality of life, evolution of minimally invasive procedures. The uterine fibroids treatment market size is expected to see strong growth in the next few years. It will grow to " $6.43 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to advancements in non-invasive treatment, increasing emphasis on fertility preservation, rise in minimally invasive techniques, personalized medicine approaches, collaborative research and development. Major trends in the forecast period include rising focus on fertility-preserving treatments, integration of imaging technologies in treatment planning, increasing awareness and education initiatives, customized treatment plans based on patient profiles, exploration of novel therapeutic targets. For further insights on this market, request a sample here

The uterine fibroids treatmentmarket covered in this report is segmented –
1) By Type: Subserosal Fibroids; Intramural Fibroids; Submucosal Fibroids; Pedunculated Fibroids
2) By Treatment Type: Hormone Therapy; Androgens; Gonadotropin-Releasing Hormone Antagonists; Uterine Artery Embolization; Myomectomy; Hysterectomy
3) By End-Users: Hospitals; Ambulatory Surgical Centers; Other End users Subsegments:
1) By Subserosal Fibroids: Pedunculated Subserosal Fibroids; Non-Pedunculated Subserosal Fibroids
2) By Intramural Fibroids: Small Intramural Fibroids; Large Intramural Fibroids
3) By Submucosal Fibroids: Pedunculated Submucosal Fibroids; Non-Pedunculated Submucosal Fibroids
4) By Pedunculated Fibroids: Subserosal Pedunculated Fibroids; Submucosal Pedunculated Fibroids For further insights on this market, request a sample here

North America was the largest region in the uterine fibroids treatment market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the uterine fibroids treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on this market, request a sample here.

Major companies operating in the uterine fibroids treatment market include Gynesonics Inc., Medtronic plc, Boston Scientific Corporation, Karl Storz GmbH, Pfizer Inc., Abbvie Inc., Richard Wolf GmbH, CooperSurgical Inc., Olympus Corporation, Myovant Sciences GmbH, Insightec Ltd., Hologic Inc., Obseva SA, Eli Lilly and Company, GlaxoSmithKline plc, Stryker Corporation, Smith & Nephew plc, Minerva Surgical Inc., Ethicon Inc., Cook Medical LLC, C.R. Bard Inc., Biomerics LLC, Visionsense Corp., Halt Medical Inc., Acessa Health Inc., Blue Endo, LiNA Medical ApS, Merit Medical Systems Inc., Allergan plc, Astellas Pharma Inc. . For further insights on this market, request a sample here.

Major trends in this market include Innovative Uterine Fibroid Treatment Kissei Launches Non-Hormonal Therapy YSELTY. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Uterine Fibroids Treatment Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon